| 000 | 01346 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514162204.0 | ||
| 264 | 0 | _c20040302 | |
| 008 | 200403s 0 0 eng d | ||
| 022 | _a0007-0963 | ||
| 024 | 7 |
_a10.1046/j.0366-077x.2003.05628.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBilu, Donna | |
| 245 | 0 | 0 |
_aImiquimod: modes of action. _h[electronic resource] |
| 260 |
_bThe British journal of dermatology _cNov 2003 |
||
| 300 |
_a5-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xtherapeutic use |
| 650 | 0 | 4 |
_aAminoquinolines _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigen-Presenting Cells _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImiquimod |
| 650 | 0 | 4 | _aImmunologic Memory |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xdrug effects |
| 650 | 0 | 4 |
_aSkin Diseases, Viral _xdrug therapy |
| 650 | 0 | 4 | _aStimulation, Chemical |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aToll-Like Receptors |
| 650 | 0 | 4 |
_aViral Vaccines _xsupply & distribution |
| 700 | 1 | _aSauder, D N | |
| 773 | 0 |
_tThe British journal of dermatology _gvol. 149 Suppl 66 _gp. 5-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.0366-077x.2003.05628.x _zAvailable from publisher's website |
| 999 |
_c14353387 _d14353387 |
||